 |
 |
MIKE LILLESTOL, MD, FACP
Research: Open Studies
To learn more about any of the current open clinical trials,
call 701-232-7705 or 1-866-532-7705.
Publications:
|
September 2006 - Present - Investigator
Amgen Registrat
A multi-center, prospective, observational study to determine the pattern of care and health and economic outcomes associated with bone loss in postmenopausal women.
|
July 2006 - Present - Investigator
GlaxoSmith Kline
A 26-week, parallel-group,double-blind, randomized, placebo-controlled, multi-center, dose-ranging study to evaluate the efficacy, safety and tolerability of three doses of GW823093 in subjects with type 2 diabetes mellitus followed by a 26-week, open-label, active treatment extension.
|
| May
2006 - Present - Investigator
Bausch & Lomb Protocol # 434
A Study To Evaluate
The Clinical And Microbial Efficacy Of 0.6% ISV-403
Compared To VIgagmox In The Treatment Of Bacterial Conjunctivitis
|
May 2006 -
Present - Investigator
Novartis Pharmaceuticals CVEA489A2302
An 8-week, multicenter,
randomized, double-blind, parallel-group study to evaluate
the efficacy and safety of the combination of valsartan/HCTZ/amlodipine
compared to valsartan/HCTZ, valsartan/amlodipine, and
HCTZ/amlodipine in patients with moderate to severe hypertension
|
August 2005
- Present - Investigator
Sanofi-Aventis EFC 5555
A placebo-controlled, double-blind,
parallel arm trial to assess the efficacy of dronedarone
400 mg bid for the prevention of cardiovascular hospitalization
or death from any cause in patients with atrial fibrillation/atrial
flutter (AF/AFL) "ATHENA" trial
|
May 2005 -
Present - Investigator
Amgen 20010284
Trial to reduce cardiovascular events with Aranesp®
Therapy. "TREAT" protocol
|
|
|
